Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.

PloS One
Betty T TaoDavid G Taylor

Abstract

Diabetes costs represent a large burden to both patients and the health care system. However, few studies that examine the economic consequences of diabetes have distinguished between the two major forms, type 1 and type 2 diabetes, despite differences in underlying pathologies. Combining the two diseases implies that there is no difference between the costs of type 1 and type 2 diabetes to a patient. In this study, we examine the costs of type 1 diabetes, which is often overlooked due to the larger population of type 2 patients, and compare them to the estimated costs of diabetes reported in the literature. Using a nationally representative dataset, we estimate yearly and lifetime medical and indirect costs of type 1 diabetes by implementing a matching method to compare a patient with type 1 diabetes to a similar individual without the disease. We find that each year type 1 diabetes costs this country $14.4 billion (11.5-17.3) in medical costs and lost income. In terms of lost income, type 1 patients incur a disproportionate share of type 1 and type 2 costs. Further, if the disease were eliminated by therapeutic intervention, an estimated $10.6 billion (7.2-14.0) incurred by a new cohort and $422.9 billion (327.2-519.4) incurr...Continue Reading

References

Mar 17, 1989·JAMA : the Journal of the American Medical Association·W G ManningJ Wasserman
Jan 1, 1983·Social Science & Medicine·R E Leu, T Schaub
Nov 1, 1995·Journal of the American Dietetic Association·A N KoehlerJ S Dorman
Oct 20, 1999·Archives of Internal Medicine·D ThompsonG Oster
Mar 5, 2002·Pediatrics·John H DiLibertiKenneth McCormick
May 22, 2002·Annals of the New York Academy of Sciences·Mona Landin-Olsson
Jul 9, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·M BalmeT M E Davis
Dec 28, 2002·Diabetes Care·UNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Mar 1, 2003·Diabetes Care·Paul HoganUNKNOWN American Diabetes Association
Jul 24, 2003·Archives of Disease in Childhood·N VisalliUNKNOWN IMDIAB Group
Sep 23, 2003·Reviews in Endocrine & Metabolic Disorders·Ramachandra G Naik, Jerry P Palmer
Jan 27, 2005·Annals of Family Medicine·Richelle J KoopmanMark E Geesey
Mar 1, 2005·Diabetes Care·Michael CusickUNKNOWN Early Treatment Diabetc Retinopathy Study Research Group
Sep 28, 2005·Diabetes Care·Gisela Dahlquist, Bengt Källén
Apr 29, 2006·Diabetes Care·Spiros FourlanosPeter G Colman
Aug 17, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·B MiltonM Whitehead
Aug 17, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·UNKNOWN DIAMOND Project Group
Sep 1, 2006·PharmacoEconomics·Ebere AkobunduC Daniel Mullins
Nov 2, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Onur Baser
Jan 5, 2007·Reviews in Endocrine & Metabolic Disorders·Hui Peng, William Hagopian
Jul 25, 2007·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A IcksG Giani
Mar 1, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Apr 14, 2009·Population Health Management·Timothy M DallShiping Zhang
Nov 27, 2009·Diabetes Care·Elbert S HuangJames C Capretta

❮ Previous
Next ❯

Citations

May 13, 2014·Diabetes Research and Clinical Practice·Charmaine S NgYu Ko
Oct 7, 2014·Interface Focus·Marie Csete, John Doyle
Dec 2, 2014·Diabetes Technology & Therapeutics·Robert A Gabbay, Erin L McGinley
Feb 22, 2013·Current Opinion in Endocrinology, Diabetes, and Obesity·Benjamin H FryerMark C Zimmerman
Nov 16, 2011·International Journal of Food Sciences and Nutrition·Matthew Metzgar
Feb 4, 2014·Canadian Journal of Diabetes·Marco LauTom Elliott
Dec 21, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Emily K Sims, Carmella Evans-Molina
Jan 23, 2016·PharmacoEconomics·Martin HenrikssonMichael Willis
Oct 27, 2012·Endocrinology and Metabolism Clinics of North America·Diana E StanescuTerri H Lipman
Aug 21, 2010·Endocrinology and Metabolism Clinics of North America·Betty T Tao, David G Taylor
Jan 4, 2012·Annals of the New York Academy of Sciences·Brian P Boerner, Nora E Sarvetnick
Mar 28, 2013·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Sharon Grundfest-Broniatowski
Feb 18, 2011·Clinical Transplantation·Jessica BeckwithHenk-Jan Schuurman
Jan 17, 2013·Journal of the American Society of Hypertension : JASH·Erdal SafakRalf Dechend
Jun 19, 2015·Pediatric Diabetes·Rita Bottino, Massimo Trucco
May 29, 2014·Population Health Management·Mary E CostantinoJonathan R Bouchard
Mar 18, 2011·Diabetes Care·Casey CrumpJan Sundquist
Mar 31, 2015·PloS One·Charmaine Shuyu NgJoyce Yu-Chia Lee
Aug 24, 2013·PloS One·Christina BächleUNKNOWN DPV Initiative and the German BMBF Competence Network Diabetes Mellitus
Sep 7, 2016·Journal of Diabetes Research·Amin Al-AwarCsaba Varga
Jul 23, 2016·Pediatric Diabetes·Feneli KarachaliouKyriaki Karavanaki
Oct 19, 2017·Current Diabetes Reports·Carla GreenbaumDana VanBuecken
Aug 31, 2016·Pediatric Diabetes·Kristen E McCabeKenneth B DeSantes
Oct 31, 2017·Current Diabetes Reports·Maria J RedondoAndrea K Steck
Jan 22, 2018·Journal of Endocrinological Investigation·S C DeShields, T D Cunningham
Aug 28, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Sara RamzanZaheer-Ud-Din Babar
Nov 1, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Jessica D WeaverAndrés J García
Dec 27, 2019·Journal of Diabetes Science and Technology·James A MurrayMichelle L Litchman
Dec 31, 2019·Diabetes Technology & Therapeutics·Matthew SussmanRobert Griffiths
Jun 25, 2019·Annals of Plastic Surgery·Lohrasb R SayadiAlan D Widgerow
Feb 28, 2020·Journal of Managed Care & Specialty Pharmacy·Vijay N JoishJeremy Pettus
Feb 16, 2020·Pediatric Diabetes·Stephanie CrossenJeffrey S Hoch
Sep 19, 2019·The Journal of Clinical Endocrinology and Metabolism·Lena-Katharina RadermacherGeorge J Kahaly

❮ Previous
Next ❯

Software Mentioned

MEPS
LADA

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.